USPTO serial 86356058
DV BIOLABS
Reviewed by CopyMark Law Group
Reg. 4839407Status 710
- Filing date
- Status date
- Registration date
- Oct 27, 2015
- Examiner
- ENGEL, MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with DV BIOLABS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Regeneration Worldwide Company Inc.
Panama City, PA
Other trademarks owned by Regeneration Worldwide Company Inc.
Regeneration Worldwide Company Inc.
Panama City, PA
Other trademarks owned by Regeneration Worldwide Company Inc.
Regeneration Worldwide Company Inc.
Panama City, PA
Other trademarks owned by Regeneration Worldwide Company Inc.
PANAMA, PA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dr. Darius Gleason, Esq.
Dr. Darius Gleason, Esq. Law Office of Darius Gleason APC4897 Main StreetYorba Linda, CA 92886UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Tissue adhesive in the form of medical adhesives for bonding inner tissue; biological preparations for the treatment of proliferative, infectious, cell-proliferative, autoimmune, inflammatory, metabolic, cardiovascular, respiratory, neurological diseases, joint disorders, and musculoskeletal disorders and diseases and other diseases; biological preparations for medical use for the treatment of proliferative, infectious, cell-proliferative, autoimmune, inflammatory, metabolic, cardiovascular, respiratory, neurological diseases, joint disorders, and musculoskeletal disorders and diseases and other diseases; stem cells for medical or veterinary use; cultured cells for clinical use; autologous cells for medical or clinical use; allogeneic cells for medical or clinical use; medicinal dermatological preparations for body and beauty care; gene therapy products, namely, tissues made by means of genetic engineering for transplantation; live tissues for surgical transplants of blood plasma and blood products for medical use; blood plasma; blood for medical purposes | SECTION 8 - CANCELLED | — |
| 039 | Biomedical services, namely, the storage of human cells for medical use; transporting, storing and packaging of biological and medical samples; storage of tissue, blood, blood components, blood derived products and stem cells; storage of white blood cells | SECTION 8 - CANCELLED | — |
| 040 | Cryogenic preservation; cryogenic preservation of biological tissue or cells intended for subsequent implantation; cryogenic preservation of blood and blood components; adipose tissue perivascular stem cell cryogenic preservation services; cryogenic preservation of biological and medical samples for transport; preparation and treatment of biological and medical samples for transport; preservation of biological material, namely, long-term preservation of biological material through freezing process; cryogenic preservation of women's oocytes for potential future use in in-vitro fertilization; umbilical cord tissue perivascular stem cell cryogenic preservation; processing and cryogenic preservation of stem cells from umbilical cord or placental blood; freezing, by means of cryopreservation and thawing of white blood cells | SECTION 8 - CANCELLED | — |
| 042 | Biopharmaceutical development, research and evaluation services of stem cell-based therapeutics for the treatment of disease, injuries and disorders; biotechnology laboratory services; analysis of biological samples; scientific laboratory services in the field of cell expansion technology for derivation, expansion, transformation, and multiplication of cells | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Regeneration Worldwide Company Inc.
- Other trademarks owned by Regeneration Worldwide Company Inc.
- Other trademarks owned by Regeneration Worldwide Company Inc.
- Other trademarks owned by REGENERACION TERAPEUTICA S.A.
- Other trademarks in Class 005
- Other trademarks in Class 039
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named DV BIOLABS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 13, 2022 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Oct 27, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 25, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 6, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 6, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 27, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 6, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 1, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 30, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 30, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 30, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 30, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 30, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 21, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2015 | ALIE | ASSIGNED TO LIE | — |
| May 13, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 13, 2014 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Aug 12, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 7, 2014 | NWAP | NEW APPLICATION ENTERED | — |